NP Life Sciences Health Industry Group Inc. (ACAT)

0.05 -64.09% (-0.10)

Over 1M: -94.0%

2024-07-15
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

0.25 0.5 0.75
7 Dec 13 Jul 6 Dec 31 Jan 10 Apr 3 May 3 Jul

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q1 '19 — Operating Cash Flow: -52.1K Q1 '19 — Net Income: -29.7K Q2 '19 — Operating Cash Flow: -22.1K Q2 '19 — Net Income: -5K Q3 '19 — Operating Cash Flow: -5.1K Q3 '19 — Net Income: -31.9K Q4 '19 — Operating Cash Flow: 75.1K Q4 '19 — Net Income: -42.3K Q1 '20 — Operating Cash Flow: -20.7K Q1 '20 — Net Income: -30.1K Q2 '20 — Operating Cash Flow: -53.7K Q2 '20 — Net Income: -53.7K Q3 '20 — Operating Cash Flow: -23.5K Q3 '20 — Net Income: -25.6K Q4 '20 — Operating Cash Flow: -26.4K Q4 '20 — Net Income: -21.7K Q1 '21 — Operating Cash Flow: -29.2K Q1 '21 — Net Income: -24.2K Q2 '21 — Operating Cash Flow: -48.7K Q2 '21 — Net Income: -52.7K Q3 '21 — Operating Cash Flow: -15.7K Q3 '21 — Net Income: -20.8K Q4 '21 — Operating Cash Flow: 3K Q4 '21 — Net Income: 32.1K Q1 '22 — Operating Cash Flow: -4.9K Q1 '22 — Net Income: -31.1K Q2 '22 — Operating Cash Flow: -22.5K Q2 '22 — Net Income: 1.1K Q3 '22 — Operating Cash Flow: 6.4K Q3 '22 — Net Income: -5.4K Q4 '22 — Operating Cash Flow: 114.9K Q4 '22 — Net Income: 16.6K Q1 '23 — Operating Cash Flow: 18.2K Q1 '23 — Net Income: 1.2K Q2 '23 — Operating Cash Flow: -37.3K Q2 '23 — Net Income: 71.2K Q3 '23 — Operating Cash Flow: -40.6K Q3 '23 — Net Income: -37.7K Q4 '23 — Operating Cash Flow: -13.9K Q4 '23 — Net Income: -37.7K -35K 0 35K 70K 105K 140K
Q2 '19 Q1 '20 Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '23
Operating Cash Flow Free Cash Flow Net Income

Figures as at 2023-12-31, reported in USD. The newest fact in the filings is dated 2023-12-31, 973 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

3.0
OE margin -44.7%
Oper. margin -0.42%
Accruals 91.9%
FCF margin -44.7%
OCF margin -44.7%
ROA -3.8%
ROCE -1.8%
ROE -17.9%
Capex / sales —
EBITDA margin —
Gross margin —
OCF / EBIT —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.5
RPO / sales 0.061×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
ND/EBITDA —
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 7.3×
Cash runway 0.96 yr
F-score 4.5 pts
Cash / Debt —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

8.4
Sales CAGR 4Y +39.9%
Sales Q/Q -78.3%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales/sh Y/Y —

3 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.